Exclusive

Publication

Byline

Location

US Patent Issued to IMMUNOCORE on Aug. 4 for "Engineered immune-mobilizing T-cell receptors with enhanced affinity for HIV-1 gag" (British Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,316, issued on Aug. 4, was assigned to IMMUNOCORE Ltd. (Abingdon, Great Britain). "Engineered immune-mobilizing T-cell receptors with enhanc... Read More


US Patent Issued to CRISPR Therapeutics on Aug. 4 for "Manufacturing process for making t cells expressing chimeric antigen receptors" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,317, issued on Aug. 4, was assigned to CRISPR Therapeutics AG (Zug, Switzerland). "Manufacturing process for making t cells expressing chime... Read More


US Patent Issued to CASE WESTERN RESERVE UNIVERSITY on Aug. 4 for "Long lived T cells for treating HIV infection" (Ohio Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,318, issued on Aug. 4, was assigned to CASE WESTERN RESERVE UNIVERSITY (Cleveland). "Long lived T cells for treating HIV infection" was inve... Read More


US Patent Issued to Protean Bio, University of New South Wales on Aug. 4 for "Peptides for beta-cell survival and insulin production" (Australian, American Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,319, issued on Aug. 4, was assigned to Protean Bio Inc. and University of New South Wales (Sydney). "Peptides for beta-cell survival and ins... Read More


US Patent Issued to 20BLOC on Aug. 4 for "Hemoglobin-based oxygen carrier compositions" (California, Minnesota Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,320, issued on Aug. 4, was assigned to 20BLOC INC. (Thousand Oaks, Calif.). "Hemoglobin-based oxygen carrier compositions" was invented by A... Read More


US Patent Issued to California Institute of Technology on Aug. 4 for "Antibodies which have specificity to a sarbecovirus spike protein receptor-binding domain and methods of use thereof for treating a coronavirus infection" (California Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,321, issued on Aug. 4, was assigned to California Institute of Technology (Pasadena, Calif.). "Antibodies which have specificity to a sarbec... Read More


US Patent Issued to Genentech on Aug. 4 for "Methods for modulating host cell surface interactions with SARS-CoV-2" (California Inventor)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,322, issued on Aug. 4, was assigned to Genentech Inc. (South San Francisco, Calif.). "Methods for modulating host cell surface interactions ... Read More


US Patent Issued to Kymab on Aug. 4 for "Antagonists" (British Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,323, issued on Aug. 4, was assigned to Kymab Ltd. (Cambridge, Great Britain). "Antagonists" was invented by Volker Germaschewski (Cambridge,... Read More


US Patent Issued to NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA on Aug. 4 for "Cystic lymphangioma treatment drug" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,324, issued on Aug. 4, was assigned to NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA (Toyama, Japan). "Cystic lymphangioma treatment ... Read More


US Patent Issued on Aug. 4 for "Biological binding molecules" (German Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,325, issued on Aug. 4. "Biological binding molecules" was invented by Holger Klapproth (Freiburg i. Br., Germany), Marc A. Kessemeier (Emmen... Read More